Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells
- 1 December 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 17 (Supplement) , 1873-1877
- https://doi.org/10.1097/00004872-199917121-00015
Abstract
Objective To investigate whether angiotensin II type 2 (AT2) receptor (AT2-r) promoter activity and expression are modulated by angiotensin II (Ang II), and whether the AT1 receptor (AT1-r) is involved in this effect. Design and methods Primary endothelial cells obtained from neonatal rat aorta, expressing both receptors, were transfected with the rat AT2-r promoter region cloned into a pCAT-reporter vector. The reporter-expression study was performed in a transient transfection assay system. Transfected cells were studied following angiotensin-converting enzyme inhibition to prevent endogenous formation of Ang II. Cells were subsequently stimulated for 6 h with Ang II, either alone or in combination with the AT1-r antagonist DuP753. AT2-r mRNA was assessed by RNase protection assay during the same pharmacological stimuli. Results Stimulation with Ang II caused an increase in promoter activity (+50%, P P P 2-r mRNA accumulation (P 2-r antagonist PD123319 indicate that the AT2-r is also involved in the regulation of AT2-r gene promoter activity. Conclusions These data indicate that Ang II increases AT2-r promoter activity and decreases AT2-r mRNA accumulation in endothelial cells. The AT1 subtype receptor is involved in the modulation of both effects of Ang II. These findings suggest that changes in the expression of AT2 receptors may occur during treatment with AT1-r antagonists, and they indicate the existence of a cross-talk between AT1 and AT2 receptors.This publication has 20 references indexed in Scilit:
- Modulation of the Vascular Smooth Muscle Angiotensin Subtype 2 (AT2) Receptor by Angiotensin IIBiochemical and Biophysical Research Communications, 1998
- Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell.Journal of Clinical Investigation, 1998
- Up-regulation of Angiotensin Type 2 Receptor mRNA by Angiotensin II in Rat Cortical CellsBiochemical and Biophysical Research Communications, 1997
- Angiotensin II Receptor Subtypes AT1 and AT2 Are Down-Regulated by Angiotensin II through AT1 Receptor by Different MechanismsEndocrinology, 1997
- The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.Journal of Clinical Investigation, 1995
- Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cellsEndocrinology, 1994
- Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cellsBiochemical and Biophysical Research Communications, 1992
- Expression of AT2 receptors in the developing rat fetus.Journal of Clinical Investigation, 1991
- Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptorNature, 1991
- Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesisBiochemistry, 1971